AWS GraphRAG deployment speeds drug research cycles

A recent AWS GraphRAG deployment has reduced drug research and development cycles in pharmaceutical settings by 87%, according to the report. The system connects previously separate internal databases into a single knowledge graph that researchers can query in natural language. The setup uses Amazon Neptune Analytics, Amazon Bedrock, and related AWS services to combine structured and unstructured sources such as clinical metrics, lab notes, and public research databases. By linking these sources, teams can retrieve relevant information faster and preserve project context that might otherwise be lost when staff change. The article says early adopters saw discovery phases fall from about six months to roughly three weeks, along with faster data retrieval and shorter review times. It also notes that the approach requires careful data governance, schema control, and citation tracking to reduce mapping errors and hallucinations.